Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Hoffmann

Showing results (71-80 of 142) with videos related to

Pageof 15
Sort By:
The European Respiratory Journal|November 15, 2011
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapyArne Warth, Stephan Macher-Goeppinger, Thomas Muley, et al.
International Journal of Cancer|March 25, 2006
Molecular determinants of response to RTK-targeting agents in nonsmall cell lung cancerNiels Reinmuth, Michael Meister, Thomas Muley, et al.
Oncoimmunology|November 18, 2017
Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancerSeyer Safi, Yoshikane Yamauchi, Anchana Rathinasamy, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 22, 2010
The efficacy of bipolar and multipolar radiofrequency ablation of lung neoplasms - results of an ablate and resect studyThomas Schneider, David Reuss, Arne Warth, et al.
The European Respiratory Journal|March 13, 2012
Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomasArne Warth, Albrecht Stenzinger, Ann-Christin von Brünneck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survivalArne Warth, Thomas Muley, Michael Meister, et al.
BMC Cancer|December 22, 2015
A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial)Seyer Safi, Philipp Beckhove, Arne Warth, et al.
Histopathology|August 14, 2012
Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsiesArne Warth, Thomas Muley, Esther Herpel, et al.
Respiration; International Review of Thoracic Diseases|September 19, 2018
Survival after Endoscopic Valve Therapy in Patients with Severe EmphysemaDaniela Gompelmann, Nicola Benjamin, Elena Bischoff, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
The dynamic pattern of recurrence in curatively resected non-small cell lung cancer patients: Experiences at a single institutionYoshikane Yamauchi, Thomas Muley, Seyer Safi, et al.
Pageof 15

Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
The European Respiratory Journal|November 15, 2011
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapyArne Warth, Stephan Macher-Goeppinger, Thomas Muley, et al.
International Journal of Cancer|March 25, 2006
Molecular determinants of response to RTK-targeting agents in nonsmall cell lung cancerNiels Reinmuth, Michael Meister, Thomas Muley, et al.
Oncoimmunology|November 18, 2017
Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancerSeyer Safi, Yoshikane Yamauchi, Anchana Rathinasamy, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 22, 2010
The efficacy of bipolar and multipolar radiofrequency ablation of lung neoplasms - results of an ablate and resect studyThomas Schneider, David Reuss, Arne Warth, et al.
The European Respiratory Journal|March 13, 2012
Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomasArne Warth, Albrecht Stenzinger, Ann-Christin von Brünneck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survivalArne Warth, Thomas Muley, Michael Meister, et al.
BMC Cancer|December 22, 2015
A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial)Seyer Safi, Philipp Beckhove, Arne Warth, et al.
Histopathology|August 14, 2012
Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsiesArne Warth, Thomas Muley, Esther Herpel, et al.
Respiration; International Review of Thoracic Diseases|September 19, 2018
Survival after Endoscopic Valve Therapy in Patients with Severe EmphysemaDaniela Gompelmann, Nicola Benjamin, Elena Bischoff, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
The dynamic pattern of recurrence in curatively resected non-small cell lung cancer patients: Experiences at a single institutionYoshikane Yamauchi, Thomas Muley, Seyer Safi, et al.
Pageof 15